Photodynamic therapy of bladder cancer: A new option;Die photodynamische Therapie des Harnblasenkarzinoms: Eine neue Option

Urologe - Ausgabe A

Volumn 52, Issue 9, 2013, Pages 1225-1232

  Neuhaus, J ^a   Schastak, S ^a   Berndt, M ^a   Walther, J ^a   Dietel, A ^a   Sieger, N ^a   Stolzenburg, J U ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Cell culture; Photosensitizer; Tetrahydroporphyrin tetratosylate; Tissue penetration depth; Topical administration

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER; PHOTOSENSITIZING AGENT; TETRAHYDROPORPHYRIN TETRATOSYLATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; NONHUMAN; PHOTODYNAMIC THERAPY; RAT;

ANIMALS; CELL LINE, TUMOR; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RATS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84884679032     PISSN: 03402592     EISSN: 14330563     Source Type: Journal    
DOI: 10.1007/s00120-013-3306-2     Document Type: Article

References (30)

1. Asanuma H, Arai T, Morimoto Y et al (2005) Photodynamic therapy with PAD-S31, a new hydrophilic chlorin photosensitizer, in an orthotopic rat bladder tumor model. J Urol 174:2016-2021
2. Babjuk M, Oosterlinck W, Sylvester R et al (2012) Guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS). EAU Guidelines 1-35
3. Braathen LR, Szeimies RM, Basset-Seguin N et al (2007) Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 56:125-143
4. Castano AP, Mroz P, Hamblin MR (2006) Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6:535-545
5. El Khatib S, Berrahmoune S, Leroux A et al (2006) A novel orthotopic bladder tumor model with predictable localization of a solitary tumor. Cancer Biol Ther 5:1327-1331
6. Epstein JI, Amin MB, Reuter VR, Mostofi FK (1998) The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22:1435-1448
7. Goeckenjan G, Sitter H, Thomas M et al (2011) Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie 65:39-59
8. Gomer CJ, Ryter SW, Ferrario A et al (1996) Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins. Cancer Res 56:2355-2360
9. Gronlund-Pakkanen S, Wahlfors J, Talja M et al (2003) The effect of photodynamic therapy on rat urinary bladder with orthotopic urothelial carcinoma. BJU Int 92:125-130
10. Huang YY, Tanaka M, Vecchio D et al (2012) Photodynamic therapy induces an immune response against a bacterial pathogen. Expert Rev Clin Immunol 8:479-494
11. Jocham D, Beer M, Baumgartner R et al (1989) Long-term experience with integral photodynamic therapy of TIS bladder carcinoma. CIBA Found Symp 146:198-208
12. Jocham D, Wietersheim J von, Pfluger H et al (2009) BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-a multicentre clinical phase III study. Aktuelle Urol 40:91-99
13. Kausch von Schmeling I (2010) Diagnosis of and therapy for non-muscle-invasive bladder cancer - state of the art. Aktuelle Urol 41:307-315
14. Lee LS, Thong PS, Olivo M et al (2010) Chlorin e6-polyvinylpyrrolidone mediated photodynamic therapy - a potential bladder sparing option for high risk non-muscle invasive bladder cancer. Photodiagnosis Photodyn Ther 7:213-220
15. Lopez-Beltran A, Montironi R (2004) Non-invasive urothelial neoplasms: according to the most recent WHO classification. Eur Urol 46:170-176
16. Madar-Balakirski N, Tempel-Brami C, Kalchenko V et al (2010) Permanent occlusion of feeding arteries and draining veins in solid mouse tumors by vascular targeted photodynamic therapy (VTP) with Tookad. PLoS One 5:e10282
17. Mi QW, Cao ZG, Jia T et al (2005) Effect of photodynamic therapy with metalloporphyrin compound on human prostate cancer PC-3 cells in vitro. Zhonghua Nan Ke Xue 11:124-129
18. Miyazaki K, Morimoto Y, Nishiyama N et al (2012) A novel homogeneous irradiation fiber probe for whole bladder wall photodynamic therapy. Lasers Surg Med 44:413-420
19. Nseyo UO (1996) Photodynamic therapy in the management of bladder cancer. J Clin Laser Med Surg 14:271-280
20. Nseyo UO, DeHaven J, Dougherty TJ et al (1998) Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a long-term experience. J Clin Laser Med Surg 16:61-68
21. Oertel M, Schastak SI, Tannapfel A et al (2003) Novel bacteriochlorine for high tissue-penetration: photodynamic properties in human biliary tract cancer cells in vitro and in a mouse tumour model. J Photochem Photobiol B 71:1-10
22. Schastak S (2010) Experimentelle Untersuchungen zur minimal-invasiven photodynamischen Therapie von Tumoren und antibiotika-resistenten Bakterien. Habilitationsschrift, Medizinische Fakultät, Universität Leipzig, S 1-123
23. Schastak S, Jean B, Handzel R et al (2005) Improved pharmacokinetics, biodistribution and necrosis in vivo using a new near infra-red photosensitizer: tetrahydroporphyrin tetratosylat. J Photochem Photobiol B 78:203-213
24. Schastak S, Yafai Y, Geyer W et al (2008) Initiation of apoptosis by photodynamic therapy using a novel positively charged and water-soluble near infra-red photosensitizer and white light irradiation. Methods Find Exp Clin Pharmacol 30:17-23
25. Skyrme RJ, French AJ, Datta SN et al (2005) A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma. BJU Int 95:1206-1210
26. Stenzl A, Cowan NC, De Santis M et al (2011) Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 59:1009-1018
27. Tan IB, Dolivet G, Ceruse P et al (2010) Temoporfin-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study. Head Neck 32:1597-1604
28. Walther MM, Delaney TF, Smith PD et al (1997) Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder. Urology 50:199-206
29. Yavari N, Andersson-Engels S, Segersten U, Malmstrom PU (2011) An overview on preclinical and clinical experiences with photodynamic therapy for bladder cancer. Can J Urol 18:5778-5786
30. Zheng JC, Zhao H, Chen B et al (2005) Effect of new photosensitizer CDHS801-mediated photodynamic therapy on bladder cancer: an experimental study. Zhonghua Yi Xue Za Zhi 85:1762-1765